$1,000 invested Merck & Co. Inc. (2023)
NYSE · MRK · reinvest dividends · adjusted close
●Result2023-01-03 — 2026-09-11
Today you would have
$1,430
+$430 (+42.95%)
MRKSPY (benchmark)
- Entry price
- $100.68
- Current price
- $143.93
- Shares
- 9.9321
- CAGR
- +10.17%
- Max Drawdown
- -43.44%
- vs SPY
- -66.40 pp
✦The story
$1,000 invested in Merck at the start of 2023 was worth $1,430 by mid-2026, a return of +43.0%. The pharmaceutical company continued to rely on its blockbuster cancer drug Keytruda while investors weighed questions about future growth. The stock lagged the S&P 500, which returned +109.4% over the same period.
#Related scenariosfor comparison
Other years for MRK